148-LB: Efficacy and Safety of Adding an Oral Hypoglycemic Agent or a GLP-1 Receptor Agonist to Insulin in Patients with Type 1 Diabetes: A Network Meta-analysis

Diabetes ◽  
2019 ◽  
Vol 68 (Supplement 1) ◽  
pp. 148-LB
Author(s):  
YOON JI KIM ◽  
SEUN DEUK HWANG ◽  
SOO LIM
Sign in / Sign up

Export Citation Format

Share Document